Literature DB >> 34547146

New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin?

D Pesqué1, E Lopez-Trujillo1, O Marcantonio1, A M Giménez-Arnau1, R M Pujol1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34547146     DOI： 10.1111/jdv.17690

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  11 in total

1.  Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab.

Authors:  G Pavia; L Gargiulo; F Spinelli; J Avagliano; M Valenti; R G Borroni; A Costanzo; A Narcisi
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-03       Impact factor: 9.228

Review 2.  SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.

Authors:  Gianluca Avallone; Pietro Quaglino; Francesco Cavallo; Gabriele Roccuzzo; Simone Ribero; Iris Zalaudek; Claudio Conforti
Journal:  Int J Dermatol       Date:  2022-02-09       Impact factor: 3.204

3.  Psoriasis exacerbation after COVID-19 vaccination in high-risk group: How to manage it?

Authors:  Mariam Kabbani; Maud Poskin; Farida Benhadou
Journal:  Dermatol Ther       Date:  2022-02-17       Impact factor: 3.858

Review 4.  SARS-CoV-2 vaccination and practical points in psoriasis patients: A narrative review.

Authors:  Zeinab Aryanian; Kamran Balighi; Parvaneh Hatami; Azadeh Goodarzi; Nessa Aghazadeh Mohandesi; Zeinab Mohseni Afshar
Journal:  Dermatol Ther       Date:  2022-03-22       Impact factor: 3.858

5.  Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics.

Authors:  Dario Graceffa; Francesca Sperati; Claudio Bonifati; Gabriele Spoletini; Viviana Lora; Fulvia Pimpinelli; Martina Pontone; Raul Pellini; Ornella Di Bella; Aldo Morrone; Antonio Cristaudo
Journal:  Front Med (Lausanne)       Date:  2022-09-06

6.  De novo psoriasis induced by ChAdOx1-S COVID 19 vaccine.

Authors:  Ahmed Zaiem; Mouna Daldoul; Talel Badri; Ghozlane Lakhoua; Widd Kaabi; Sana Rebii Debbiche; Sarrah Kastalli; Imen Aouinti; Ons Charfi; Sihem El Aidli
Journal:  Therapie       Date:  2022-08-01       Impact factor: 3.367

7.  New-onset psoriasis after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine successfully treated with ixekizumab.

Authors:  Giulio Cortonesi; Corinne Orsini; Pietro Rubegni; Emanuele Trovato
Journal:  Dermatol Ther       Date:  2022-06-08       Impact factor: 3.858

8.  New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review.

Authors:  Po-Chien Wu; I-Hsin Huang; Chuang-Wei Wang; Cheng-Chang Tsai; Wen-Hung Chung; Chun-Bing Chen
Journal:  Am J Clin Dermatol       Date:  2022-09-01       Impact factor: 6.233

9.  Reply to 'Nail psoriasis: A rare mRNA COVID-19 vaccine reaction' by Lamberti A et al.

Authors:  Angelo Ruggiero; Luca Potestio; Teresa Battista; Gabriella Fabbrocini; Matteo Megna
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-22       Impact factor: 9.228

Review 10.  Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.

Authors:  Elia Rosi; Maria Thais Fastame; Antonella Di Cesare; Gianmarco Silvi; Nicola Pimpinelli; Francesca Prignano
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.